The Lancet Infectious Diseases in conversation with
- Health & Fitness · Medicine
Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
The editorial team of The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. An audio companion to the journal, this podcast covers a broad range of topics, from mpox diagnostics in Africa, long COVID, adaptive trials in infectious diseases, tuberculosis drug development, and more.
Also on
Recent episodes
- Fernando Tortosa and Ariel Izcovich on hantavirus infections
- Brecht Ingelbeen and Daniel Valia on a community-based antimicrobial stewardship intervention in Burkina Faso and DRC
- Sara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California
- Jenny Clarke and Herve Semukunzi
- Julia Moore Vogel and Danilo Buonsenso on long COVID
- In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
- Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases
- Catherine Liu and Joshua Hill on prevention and management of infections in people who are immunocompromised
- Lilian Tina Minja and Norbert Heinrich on TB drug development
- Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile